Datopotamab deruxtecan in breast cancer treatment: a systematic review of clinical efficacy and safety
BackgroundBreast cancer (BC) remains the most common malignant tumor in women worldwide and a leading cause of cancer-related deaths. Despite therapeutic advances, patients with advanced BC, particularly triple-negative breast cancer (TNBC), still face…